Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001209191-17-041626

Options or other derivatives

  • VP, Clinical Research acquired 140,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Feldman Maria VP, Clinical Research 2017-06-22 Grant or award · Employee Stock Option (Right to Buy) +140,000 140,000 D
Loading xslF345X03/doc4.xml…